Back to Journals » Drug Design, Development and Therapy » Volume 12

Review

Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer

       
Total article views   HTML views PDF downloads Totals
17,904 Dovepress* 12,992+ 1,653 14,645
PubMed Central* 4,912 1,173 6,085
Totals 17,904 2,826 20,730
*Since 21 March 2018
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar